TSHR

Advertisement

cGxPJobs Banner

Yarrow Bioscience Completes VYNE Merger, Advances YB-101 into Phase 2 Trial

New Haven, Connecticut, July 27, 2026 Yarrow Bioscience, Inc. announced the successful completion of its merger with VYNE Therapeutics...

By cGxPwire Editor
July 28, 2026

Read More

Innovent Highlights Bispecific Antibody Pipeline at ATS and ARVO 2026

SAN FRANCISCO and SUZHOU, China, May 18, 2026 Innovent Biologics presented new clinical and preclinical data from its next-generation...

By cGxPwire Editor
May 20, 2026

Read More

Advertisement

cGxPJobs

Directory